Efficacy and Safety of ACC017 Tablets Compared With Dolutegravir Sodium Tablets in Treatment-Naïve Adults With Human Immunodeficiency Virus Type 1 (HIV-1)

NCT07711223 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

660

Enrollment

INDUSTRY

Sponsor class

Conditions

Infection, Human Immunodeficiency Virus

Interventions

DRUG: ACC017+FTC/TAF
DRUG: DTG+FTC/TAF

Sponsor

Jiangsu Aidea Pharmaceutical Group Co., Ltd.